Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Tunn, U W"'
Publikováno v:
Prostate Cancer & Prostatic Diseases. 2012, Vol. 15 Issue 3, p296-302. 7p.
Autor:
Tunn, U. W.1 Tunn@em.uni-frankfurt.de, Wiedey, K.2
Publikováno v:
Prostate Cancer & Prostatic Diseases. 2009, Vol. 12 Issue 1, p83-87. 5p. 3 Charts, 3 Graphs.
Publikováno v:
Journal of urology, 154(2 Part 1), 399-401. Elsevier Inc.
We tested the theoretical concept that a selective decrease in estrogens has a beneficial therapeutic effect on established benign prostatic hyperplasia. In a double-blind study 160 patients from 14 centers were randomized between 2 groups to receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::48807ed0be13ff2a2b07abf6fb9fa3fc
https://pure.amc.nl/en/publications/placebo-controlled-doubleblind-study-to-test-the-efficacy-of-the-aromatase-inhibitor-atamestane-in-patients-with-benign-prostatic-hyperplasia-not-requiring-operation-the-schering-90062-study-group(6f7fa9cb-6650-4027-a01b-a4ae21730c27).html
https://pure.amc.nl/en/publications/placebo-controlled-doubleblind-study-to-test-the-efficacy-of-the-aromatase-inhibitor-atamestane-in-patients-with-benign-prostatic-hyperplasia-not-requiring-operation-the-schering-90062-study-group(6f7fa9cb-6650-4027-a01b-a4ae21730c27).html
Publikováno v:
Journal of urology, 150(6), 1840-1844. Elsevier Inc.
A total of 171 patients with progressive metastatic prostate cancer following hormonal therapy was randomized to receive either 560 to 700 mg. estramustine orally per day or 15 mg./m.2 mitomycin C by intravenous infusion every 6 weeks. The patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::1b49af5c462943d9b3ba987be841c778
https://pure.amc.nl/en/publications/mitomycin-c-versus-estramustine-in-the-treatment-of-hormone-resistant-metastatic-prostate-cancer-the-final-analysis-of-the-european-organization-for-research-and-treatment-of-cancer-genitourinary-group-prospective-randomized-phase-iii-study-30865(fc53d902-e493-4ef9-9720-10bfac0b1629).html
https://pure.amc.nl/en/publications/mitomycin-c-versus-estramustine-in-the-treatment-of-hormone-resistant-metastatic-prostate-cancer-the-final-analysis-of-the-european-organization-for-research-and-treatment-of-cancer-genitourinary-group-prospective-randomized-phase-iii-study-30865(fc53d902-e493-4ef9-9720-10bfac0b1629).html
Autor:
Wendt, Thomas G, Gademann, G, Pambor, C, Grießbach, I, von Specht, H, Martin, T, Baltas, D, Kurek, R, Röddiger, S, Tunn, U W, Zamboglou, N, Eich, H T, Staar, S, Gossmann, A, Hansemann, K, Semrau, R, Skripnitchenko, R, Diehl, V, Müller, R-P, Sehlen, S
Publikováno v:
Strahlentherapie und Onkologie; Jun2004 Supplement, Vol. 180, p5-87, 83p
Publikováno v:
Der Urologe A; Jan2000, Vol. 39 Issue 1, p9-13, 5p
Publikováno v:
Aktuelle Urologie; 1996, Vol. 27 Issue 5, p281-286, 6p
Publikováno v:
Aktuelle Urologie; 1993, Vol. 24 Issue 6, p342-350, 9p
Publikováno v:
Aktuelle Urologie; 1992, Vol. 23 Issue 1, p21-24, 4p
Autor:
Schweikert, H. U., Tunn, U. W.
Publikováno v:
Zeitschrift für Urologie und Nephrologie; 1985, Vol. 16 Issue 2, p64-68, 5p